WAVE Share Price Performance
CA$0.02
0.01 (33.33%)
Price CA$0.02
Share PriceCA$0.02
Waverley Pharma Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
WAVE Community Narratives
There are no narratives available yet.
Recent WAVE News & Updates
Waverley Pharma Inc. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.0074
- Gross Margin
- 43.14%
- Net Profit Margin
- -32.10%
- Debt/Equity Ratio
- -136.7%
Waverley Pharma Inc. Competitors
Snowflake Analysis
About WAVE
- Founded
- 2014
- Employees
- n/a
- CEO
- WebsiteView website
Waverley Pharma Inc., a biopharmaceutical company, researches, develops, and commercializes oncology therapeutics in the United Kingdom. The company develops poly ADP-ribose polymerase-1 (PARP-1) inhibitors for cancer treatment. It also operates a retail pharmacy in the United States. Waverley Pharma Inc. was founded in 2014 and is headquartered in Winnipeg, Canada.
Market Insight
Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading
Canadian Market Performance
- 7 Days: 1.1%
- 3 Months: 10.3%
- 1 Year: 22.1%
- Year to Date: 20.3%
Over the last 7 days, the market has risen 1.1%, driven by gains of 2.7% in the Materials sector. As for the past 12 months, the market is up 22%. As for the next few years, earnings are expected to grow by 11% per annum. Market details ›